Literature DB >> 12021925

How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.

Yesim Gürbüz1, Volker Kahlke, Günter Klöppel.   

Abstract

Gastric carcinoma classifications differ in their value for distinguishing tumors according to their morphological pattern, functional properties, and biological significance. In this study we evaluated which of three established classification systems is best correlated with the expression patterns of certain mucins. A total of 160 gastric carcinomas from Turkey and Germany were screened immunohistochemically for the expression of MUC1, MUC2, MUC5AC, and MUC6, and the results were related to the different tumor categories in Lauren's, Carneiro's, and Goseki's classifications. It was found that in all three classifications carcinomas belonging to the gland-forming category most commonly expressed MUC1: 78% of Goseki's grade I carcinomas, 81.1% of Lauren's intestinal type carcinomas, and 82.8% of Carneiro's glandular type. MUC2 was expressed in all Goseki grade II carcinomas, which comprise the mucinous type, while it was not significantly associated with any of the other classifications. MUC5AC was found in all Goseki grade IV carcinomas, i.e., signet ring cell carcinomas. It was also significantly associated with Carneiro's mixed type and isolated cell type carcinomas, while there was no correlation with any of Lauren's types. MUC6 failed to show a relationship with any of the categories of the various classifications. We conclude that Goseki's classification is best correlated with MUC expression patterns because it distinguishes clearly between MUC1-positive gland-forming carcinomas, MUC2-positive mucinous ones, and MUC5AC-positive signet ring cell carcinomas. It is likely that each of these gastric carcinoma types has its own carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021925     DOI: 10.1007/s00428-002-0620-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  Not all "mucinous carcinomas" are equal: time to redefine and reinvestigate the biologic significance of mucin types and patterns in the GI tract.

Authors:  N Volkan Adsay; David S Klimstra
Journal:  Virchows Arch       Date:  2005-06-08       Impact factor: 4.064

2.  Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Rita Rani Barua; Hiroshi Uozaki; Ja-Mun Chong; Tetsuo Ushiku; Rumi Hino; Moon-Sung Chang; Hideo Nagai; Masashi Fukayama
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

3.  Relationships between mucinous gastric carcinoma, MUC2 expression and survival.

Authors:  Emmanuelle Leteurtre; Farid Zerimech; Guillaume Piessen; Agnes Wacrenier; Xavier Leroy; Marie-Christine Copin; Christophe Mariette; Jean-Pierre Aubert; Nicole Porchet; Marie-Pierre Buisine
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Case report: gastric adenocarcinoma metastatic to the prostate gland.

Authors:  Ping Zhang; Yuanyi Zheng; Haitao Ran; Zhi Leng; Zhigang Wang
Journal:  J Radiol Case Rep       Date:  2010-03-01

5.  Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.

Authors:  Kristina Roessler; Stefan-P Mönig; Paul-M Schneider; Franz-Georg Hanisch; Stephanie Landsberg; Juergen Thiele; Arnulf-H Hölscher; Hans-P Dienes; Stephan-E Baldus
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

6.  Identification of a lower grade muconodular subtype of gastric mucinous cancer.

Authors:  Enrico Solcia; Ombretta Luinetti; Francesca Tava; Catherine Klersy; Federica Grillo; Nicola Pandolfo; Roberto Fiocca
Journal:  Virchows Arch       Date:  2004-10-28       Impact factor: 4.064

7.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

8.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

9.  Prognostic significance of mucin expression in gastric carcinoma.

Authors:  Belma Kocer; Atilla Soran; Gulten Kiyak; Sibel Erdogan; Abdullah Eroglu; Betül Bozkurt; Cem Solak; Omer Cengiz
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

10.  Clinicopathologic significance of gastric and intestinal phenotypic marker expression in gastric carcinomas.

Authors:  Gwang Ha Kim; Geun Am Song; Do Youn Park; Dong Hyun Lee; Tae Oh Kim; Seong Hun Lee; Jeong Heo; Dae Hwan Kang; Mong Cho
Journal:  Korean J Intern Med       Date:  2005-09       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.